PI3Ka activates integrin α4ß1 to establish a metastatic niche in lymph nodes

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 22, 2013, Pages 9042-9047

  Garmy Susini, Barbara ^a   Avraamides, Christie J ^a   Desgrosellier, Jay S ^a,b   Schmid, Michael C ^a   Foubert, Philippe ^a   Ellies, Lesley G ^b   Lowy, Andrew M ^a,b   Blair, Sarah L ^a,b   Vandenberg, Scott R ^b   Datnow, Brian ^b   Wang, Huan You ^b   Cheresh, David A ^b   Varner, Judith ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN; INTEGRIN ALPHA 4 BETA 1; PHOSPHATIDYLINOSITOL 3 KINASE; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4;

ANIMAL CELL; ARTICLE; CELL ADHESION; HUMAN; HUMAN TISSUE; IN VIVO STUDY; LYMPH NODE; LYMPH NODE METASTASIS; LYMPH VESSEL ENDOTHELIUM; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; TUMOR MICROENVIRONMENT; ANALYSIS OF VARIANCE; ANIMAL; FEMALE; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; LYMPHANGIOGENESIS; METABOLISM; METASTASIS; MOUSE; PAGET NIPPLE DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALIA;

ANALYSIS OF VARIANCE; ANIMALS; CARCINOMA, DUCTAL, BREAST; CELL ADHESION; ENDOTHELIUM, LYMPHATIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHA4BETA1; LYMPH NODES; LYMPHANGIOGENESIS; MICE; NEOPLASM METASTASIS; PHOSPHATIDYLINOSITOL 3-KINASES; VASCULAR CELL ADHESION MOLECULE-1;

MLCS; MLOWN;

EID: 84878468603     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1219603110     Document Type: Article

References (33)

1. Nguyen DX, Bos PD, Massagué J (2009) Metastasis: From dissemination to organspecific colonization. Nat Rev Cancer 9(4):274-284.
2. Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454(7203):436-444.
3. Joyce JA, Pollard JW (2009) Microenvironmental regulation of metastasis. Nat Rev Cancer 9(4):239-252.
4. Skobe M, et al. (2001) Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7(2):192-198.
5. Leong SP, et al. (2006) Clinical patterns of metastasis. Cancer Metastasis Rev 25(2):221-232.
6. Kayani B, Zacharakis E, Ahmed K, Hanna GB (2011) Lymph node metastases and prognosis in oesophageal carcinoma -A systematic review. Eur J Surg Oncol 37(9):747-753.
7. Jennbacken K, Vallbo C, Wang W, Damber JE (2005) Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis. Prostate 65(2):110-116.
8. Dadras SS, et al. (2005) Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes. Mod Pathol 18(9):1232-1242.
9. Bando H, et al. (2006) The association between vascular endothelial growth factor-C, its corresponding receptor, VEGFR-3, and prognosis in primary breast cancer: a study with 193 cases. Oncol Rep 15(3):653-659.
10. Petrova TV, et al. (2008) VEGFR-3 expression is restricted to blood and lymphatic vessels in solid tumors. Cancer Cell 13(6):554-556.
11. Chen Z, et al. (2005) Down-regulation of vascular endothelial cell growth factor-C expression using small interfering RNA vectors in mammary tumors inhibits tumor lymphangiogenesis and spontaneous metastasis and enhances survival. Cancer Res 65(19):9004-9011.
12. He Y, et al. (2005) Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res 65(11):4739-4746.
13. Garmy-Susini B, et al. (2010) Integrin alpha4beta1 signaling is required for lymphangiogenesis and tumor metastasis. Cancer Res 70(8):3042-3051.
14. Zhou F, et al. (2010) Akt/Protein kinase B is required for lymphatic network formation, remodeling, and valve development. Am J Pathol 177(4):2124-2133.
15. Patel V, et al. (2011) Decreased lymphangiogenesis and lymph node metastasis by mTOR inhibition in head and neck cancer. Cancer Res 71(22):7103-7112.
16. Hirakawa S, et al. (2005) VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 201(7):1089-1099.
17. Hirakawa S, et al. (2007) VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 109(3):1010-1017.
18. Harrell MI, Iritani BM, Ruddell A (2007) Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis. Am J Pathol 170(2):774-786.
19. Banerji S, et al. (1999) LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 144(4):789-801.
20. Wigle JT, Oliver G (1999) Prox1 function is required for the development of the murine lymphatic system. Cell 98(6):769-778.
21. Baluk P, McDonald DM (2008) Markers for microscopic imaging of lymphangiogenesis and angiogenesis. Ann N Y Acad Sci 1131:1-12.
22. Guy CT, Cardiff RD, Muller WJ (1992) Induction of mammary tumors by expression of polyomavirus middle T oncogene: A transgenic mouse model for metastatic disease. Mol Cell Biol 12(3):954-961.
23. Elices MJ, et al. (1990) VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 60(4): 577-584.
24. Guan JL, Hynes RO (1990) Lymphoid cells recognize an alternatively spliced segment of fibronectin via the integrin receptor alpha 4 beta 1. Cell 60(1):53-61.
25. Breiteneder-Geleff S, et al. (1999) Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: Podoplanin as a specific marker for lymphatic endothelium. Am J Pathol 154(2):385-394.
26. Tsirlis TD, et al. (2008) Circulating lymphangiogenic growth factors in gastrointestinal solid tumors, could they be of any clinical significance? World J Gastroenterol 14(17):2691-2701.
27. Graupera M, et al. (2008) Angiogenesis selectively requires the p110alpha isoform of PI3K to control endothelial cell migration. Nature 453(7195):662-666.
28. Schmid MC, et al. (2011) Receptor tyrosine kinases and TLR/IL1Rs unexpectedly activate myeloid cell PI3k?, a single convergent point promoting tumor inflammation and progression. Cancer Cell 19(6):715-727.
29. Shattil SJ, Kim C, Ginsberg MH (2010) The final steps of integrin activation: The end game. Nat Rev Mol Cell Biol 11(4):288-300.
30. Féral CC, et al. (2006) Blocking the alpha 4 integrin-paxillin interaction selectively impairs mononuclear leukocyte recruitment to an inflammatory site. J Clin Invest 116(3):715-723.
31. Minn AJ, et al. (2005) Genes that mediate breast cancer metastasis to lung. Nature 436(7050):518-524.
32. Chen Q, Zhang XH, Massagué J (2011) Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs. Cancer Cell 20(4): 538-549.
33. Padera TP, et al. (2002) Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 296(5574):1883-1886.